Clinical Trials in Houston

Showing 2941-2960 of 8,625 trials

Bioavailability Evaluation of CurQ+ Curcumin Formulation

NCT06177483

This study is intended to evaluate how significantly a proprietary curcumin formulation (curQ+®) results in greater bioavailability compared to 95% curcumin extract over a 6-hour time period following a single oral dose in healthy men \& women.

Bioavailability

ESM Technologies, LLC20 participantsStarted Mar 2024

Houston, Texas, United States

Active Not Recruiting< 1 mile

Breast Cancer Index (BCI) Registry

NCT04875351

The purpose of the Breast Cancer Index (BCI) Registry study is to conduct a large scale, population-based prospective registry to evaluate long-term clinical outcome, clinical impact, medication adherence and quality of life in hormone receptor positive (HR+) early-stage breast cancer patients receiving BCI testing as part of routine clinical care to inform extended endocrine therapy.

Breast Cancer

Biotheranostics, Inc.3,465 participantsStarted Apr 2021

Daphne, Alabama, United States • Mobile, Alabama, United States • Mobile, Alabama, United States +102 more locations

Bioavailability Evaluation of CurQ+ Curcumin Formulation

Breast Cancer Index (BCI) Registry

Find Trials by Condition in Houston

Motion Capture: Baseball Swing

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

A Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain

Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

Evaluation of the Diagnostic Value of the TPD System in Determining ADHF Causing Acute Dyspnea

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Air Optix® Night and Day® Aqua Continuous Wear

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients